Method and system for providing a fault tolerant display unit in an electronic device

Information

  • Patent Grant
  • 8344966
  • Patent Number
    8,344,966
  • Date Filed
    Tuesday, January 31, 2006
    18 years ago
  • Date Issued
    Tuesday, January 1, 2013
    11 years ago
Abstract
Method and apparatus for providing a fault tolerant display unit for an electronic device such as a glucose meter, including display unit, and a controller unit operatively coupled to the display unit, the controller unit configured to control the display unit to display an information, where when a failure mode of the display unit occurs, the display unit is configured to display a modified information, where the modified information is different from the information for display under the control of the controller unit, is provided.
Description
BACKGROUND

In a conventional seven segment display such as those used on LCDs (Liquid Crystal Displays), the display wiring is routed without consideration for fault tolerance, and the icon (or pixel) selection matrix is typically generated to match the display. Such configuration allows for erroneous results to be displayed and could potentially result in patient mistreatment, for example, in the case where the seven segment display configurations are used in medical devices such as, but not limited to, glucose meters.


By way of an example, a glucose reading from a blood glucose meter used by diabetic patients that shows a value of 150 when in fact the actual measured value from the test strip using the glucose meter is 450 will inform the patient that they are in a good (clinically acceptable) range when in fact, the patient's condition requires immediate medical attention, for example. In addition, a failure of a decimal point in the displayed value may also erroneously inform the patient to take corrective actions that are either inaccurate (and thus potentially harmful), or to provide the patient with false positive values (those values are erroneous readings but are good values in the context of health treatment).


While some erroneous displayed values may be acceptable and thus not medically significant (such as, for example a glucose reading of 163 mg/dL which is erroneously displayed as 153 mg/dL), those other erroneous displayed values may potentially guide the patient to take corrective actions that are in fact therapeutically inappropriate (or alternatively, providing a false sense of accuracy, to guide the patient to take no action at all, when in fact, corrective medical action is necessary, as described above).


In view of the foregoing, it would be desirable to have an approach to provide fault tolerance in the display unit of an electronic device including medical devices such that failure modes of the electronic device display unit will show output values to the patient or the user of the electronic device that are either nonsensical, or clinically insignificant. In this manner, the failed display unit of the electronic device does not erroneously impact the patient decision based on the output display of the electronic device. Moreover, when a nonsensical value is displayed, the user of the electronic device such as a medical device will be aware that the device is malfunctioning, and will likely not continue its use.


SUMMARY OF THE INVENTION

In view of the foregoing, in accordance with the various embodiments of the present invention, there is provided a method and system for fault tolerant configurations of a seven segment display of an electronic device including medical devices such as the LCD display of a glucose meter. For example, in certain embodiments if an LCD failure occurs, the result displayed will not be a number, or alternatively, the erroneous number displayed are in the A or B region of the Clarke Error Grid (that is, in the acceptable range of values in the case of measured glucose values) or analogous range of an other analysis protocol, e.g., Parks Error Grid, Continuous Glucose Error Grid, MARD analysis, and the like. Therefore, fault tolerance minimizes the chance of an incorrect number being displayed and reduces the effect of a potential error on patient treatment.


More specifically, in accordance with the various embodiments of the present invention, there is provided a fault tolerant display unit which may be configured to mitigate the effects of a display failure. More specifically, in one embodiment, if a display failure occurs (by, for example, a single pixel or multiple pixel failures), the displayed results may be configured to display an invalid number. Alternatively, in the case of glucose meters, the display failure may be mitigated by displaying, in one embodiment, measured glucose values that are within the A or B region of the Clarke Error Grid or the like, and thus, the error is not clinically significant to the patient using the glucose meter.


In this manner, in one embodiment, the probability of an incorrect value being displayed can be minimized, and the effect of a potential error on the patient treatment (based on incorrect value) may be reduced if an incorrect number is displayed.


These and other objects, features and advantages of the present invention will become more fully apparent from the following detailed description of the embodiments, the appended claims and the accompanying drawings.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a block diagram of a fault tolerant display unit for an electronic device in accordance with one embodiment of the present invention;



FIGS. 2A-2B illustrate exemplary segmented display units including icons of a blood glucose meter device;



FIG. 3A illustrates a single digit segment with icons in an LCD display unit including a decimal point segment;



FIG. 3B illustrates the single digit segment with icons in the LCD display unit including the decimal point segment of FIG. 3A with multiple common line connectors (pads) and row connections;



FIG. 4 illustrates a three digit segment of an LCD display unit with typical connections for a typical electronic device;



FIG. 5 illustrates the digits 0 to 9 of a seven-segment display used for determining fault tolerance in an LCD display unit of an electronic device in accordance with one embodiment of the present invention;



FIG. 6A illustrates a three digit segment layout with icons for an electronic device LCD display unit;



FIG. 6B illustrates the three digit segment layout of FIG. 6A with multiple row and column connections;



FIG. 7 illustrates a segmented display configuration for 3×3 mapping in a fault tolerant display system in accordance with one embodiment of the present invention;



FIG. 8 illustrates a segmented display configuration for 6×6 mapping in a fault tolerant display system in accordance with another embodiment of the present invention;



FIG. 9 illustrates a segmented display configuration for 6×4 mapping in a fault tolerant display system in accordance with still another embodiment of the present invention; and



FIG. 10 is a tabular illustration of the fault tolerant display for LCD display unit in an electronic device with varying levels of fault tolerance.





DETAILED DESCRIPTION


FIG. 1 is a block diagram of a fault tolerant display unit for an electronic device in accordance with one embodiment of the present invention. Referring to the figure, the fault tolerant display unit 100 of a blood glucose meter 101 in one embodiment includes a strip port 102 that is configured to receive a glucose test strip. The strip port 102 is coupled to a strip interface 103 which is configured to process the analog signals received from the strip port 102 and converts the signals to corresponding digital values. Also, a controller unit such as a microprocessor 104 is operatively coupled to the strip interface 103 and is configured to process the digital data received from the strip interface 103.


A crystal 105 may be provided and operatively coupled to the microprocessor 104, and configured to set timing for the microprocessor 104 such that the information or data received from the strip interface 103 has a predetermined and known timing and an accurate glucose value may be determined. Additionally, a non-volatile memory 106 may be operatively coupled to the microprocessor 104 and configured for storing program processes such as algorithms, setup and/or calibration parameters as well as glucose readings received from the strip port 102. A temporary storage device such as SRAM 107 or the like may be provided and operatively coupled to the microprocessor 104, for temporary data storage and program execution.


Also shown is a display unit 108 which may include a liquid crystal display (LCD) for output, displaying data and information. An LCD lens 109 is also provided and includes the clear section of the display unit housing that permits the LCD display unit 108 to be viewed. Input devices 110 and 111 are also provided and operatively coupled to the microprocessor 104, and configured to allow the user of the glucose meter 101 to input information and/or control the glucose meter 101 by operating as the user interface providing a user menu navigation. A control button 110 and mode button 111 may be provided to allow the user to toggle between various operational modes for the glucose meter 101 including, for example, calibration, data, recall, storage, and the like.


Referring still to FIG. 1, an audio output unit such as a buzzer 112 may be provided to provide audible alert and/or alarms, indicating a condition of the functional properties of the glucose meter 101 or, provide an audible indication of a data received by the glucose meter 101, for example. A communication module 113 is operatively coupled to the microprocessor 104, and configured to download glucose readings from a data storage log stored in the non-volatile memory 106. Moreover, a set of test points 114 may be made available within the blood glucose meter 101 housing for manufacturing processes. Additionally, a power supply 115 is provided to provide power to the blood glucose meter 101, and may include a battery 116 for example, such as, for example CR30232 Lithium Ion Coin Cell battery or the like configured as the primary power source for the power supply 115. In further detail, the battery 116 may be connected to the blood glucose meter 101 ground terminal 117, and the battery 116 may be configured to provide power to the power supply 115 positive voltage input terminal (V+) 118.


Additional features such as an LCD backlight or test light to illuminate the strip port may be provided to the blood glucose meter 101. The controller unit 104 may be a microcontroller (μC) such as the MSP430FG439 that may incorporate the strip interface 103, non-volatile memory 106, memory (SRAM) 107, controller for the LCD 108, and interface for the communications module 113. Moreover, the controller unit 104 may be configured to control the operations of the various components of the blood glucose meter 101 as shown in FIG. 1, under the control of, for example, the patient using the blood glucose meter 101 providing commands or instructions using the input units 110 or 111. In one embodiment, the blood glucose meter 101 may be configured to display glucose values in the range of about 20 mg/dL to about 500 mg/dL (or about 600 mg/dL for hospital use), or about 1.1 mmol/L to about 27.8 mmol/L (or about 33.3 mmol/L for hospital use).



FIGS. 2A-2B illustrate exemplary segmented display units including icons of a blood glucose meter device. Referring to FIG. 2A, for an electronic device, e.g., a medical device such as a blood glucose meter as shown in FIG. 1, the minimum LCD requirement includes the glucose value display (three 7-segment digits), a “mmol/L” icon (with the decimal point active), a “mg/dL” icon (with the decimal point inactive), a temperature out-of-range indicator, a low-battery indicator, and an “apply blood to test strip” set of symbols as respectively shown by the corresponding icons in FIG. 2A. Referring to FIG. 2B, additional features and or configurations of a blood glucose meter LCD display unit may include the ability to set the date and time information, and further, to display stored memory log entries (prior glucose readings) with associated date and time. Additional features may include the ability to set a strip calibration code, to display a multiple day (e.g., 14-day) average glucose reading based on log entries, set configuration options such as alarm audible or silent, and identify a glucose log entry as a control reading.



FIG. 3A illustrates a labeled or numbered single digit segment with icons in an LCD display unit including a decimal point segment, and FIG. 3B illustrates the single digit segment with icons in the LCD display unit including the decimal point segment of FIG. 3A with control signals in the form of multiple common line connectors and row connections, where each common line or row connections is known as a “pad”. Referring to FIG. 3A, each of the seven segments A, B, C, D, E, F, and G are separately provided and none are electrically connected to any of the other segments (and where each may be individually controlled).


In FIG. 3B, it can be seen that several segments are connected by one of the three row connectors and/or one of the two common (column) connectors. For example, row 1 connector as shown in FIG. 3B is connected to segments A and B, the row 2 connector is connected to segments F and G, and the row 3 connector is connected to segments C and E, while row 4 is connected to segment D and the decimal point DP. Moreover, common 1 connector as shown in FIG. 3B are connected to segments A, D, E, and F, while common 2 connector is connected to segments B, C, G and the decimal point DP segment. In this manner, in FIG. 3B, if the connection (pad) for comm 1 fails, then segments A, D, E and F will not activate and, for example, a “7” will be displayed as a “1”.



FIG. 4 illustrates a three digit segment of an LCD display unit with typical connections for an electronic device. Referring to FIG. 4, there is provided a mapping of which segments of the display are used to display each number. More specifically, it can be seen that the row and column connections only cross other rows or columns where pixels (segments) are formed. The row signals (lines) are located on one plane of the display and the common lines are located on another such that a segment (or pixel) is formed inside the LCD at the crossing point.


There are several different types of common LCD failures. A connector failure occurs when the connection between the printed circuit board (PCB) and LCD connector fails to make contact. Some examples include, but is not limited to, heat-seal failures, zebra strip failures and pad failures. A driver failure occurs when the LCD driver fails to operate properly. Some examples include ESD and other types of LCD driver failures. Finally, a connector short failure occurs when foreign material is introduced onto the connector causing two or more signals or pads to short together. When this type of failure occurs, most errors that result in a number will tend towards an eight (“8”). Since the blood glucose meter 101 does not have an eight in the first digit of its display, this type of error, though it must be checked for each individual design, tends to result in A or B region errors on the Clarke Error Grid even if they occur in the second digit, or numbers that are beyond the glucose meter range, or nonsensical numbers.


Failure modes for the blood glucose meter 101 includes (1) failure of a row or common, (2) a first digit error, (3) missing decimal point or first digit, or (4) other digit errors. When a row or common line fails, all segments connected to that row or common line fail and is commonly caused by connector failure. For example, referring for example to FIG. 4, if common 1 connector fails, all segments in the display fails to function as all seven segments of all three digits are connected to the common 1 connector.


When a first digit error occurs due to a poor connection, for example, a first digit “4” or “3” becomes a “1”, such that, for example, a “4xx” value is displayed as “1xx”, and “3xx” is displayed as “1xx”, respectively. When there is a missing decimal point or a first digit, a failure of this type generally results in a critical error and is also commonly found with a connector failure. This error results in the entire first digit not being displayed or the decimal point missing, and may result in an error as great as an entire order of magnitude. An error on this scale may result in patient mistreatment, and tends to fall in the D or E regions of the Clarke Error Grid.


When digit errors occur, a given digit of a seven segment display is erroneously displayed because of a segment failure within the seven segment display for the particular digit. Examples of digit errors are further illustrated by the Table A shown below which illustrates the original display (or the proper or accurate display) in the first column, and the actual display with the digit error in the second column, and the missing segment causing the digit error in the third column. For example, with reference to FIG. 3A and Table A below, when the seven segment digit is missing the E segment, an original display of the value “6” which comprises segments A, C, D, E, F, and G, will actually be displayed as a “5” (comprised of segments A, C, D, F, and G). For a three digit display, the first digit is the most critical (as it is the most significant value), the second digit can result in A or B region errors on the Clarke Error Grid and the third digit can only result in the A region errors making it the least critical digit.











TABLE A





Original
Number
Segments


Display
Displayed in Error
Missing







6
5
E


7
1
A


8
0
G


3
7
D, G


4
1
F, G


8
2
F, C


8
5
B, E


8
9
D, E


9
7
F, G


3
1
A, D, G


9
1
A, F, G


8
7
D, E, F, G









In the manner shown above, it can be seen that even with a single segment failure, a significant or critical error may be displayed if the failed segment is associated with the most significant digit in, for example, a three digit display unit. That is, referring to the Table A above, a failed segment G will result in the number 8” to be displayed as “0”, which error may be significant in the context of values or measurements of a patient parameter upon which medical treatment is based (note that an value of 180 displayed as a 100 is in the B region of the Clarke Error Grid in the case of glucose measurements).



FIG. 5 illustrates the digits “0” to “9” and is the basis for the method of checking for fault tolerance in an LCD display unit of an electronic device in accordance with one embodiment of the present invention. Referring to FIGS. 1 and 5, for a seven-segment digit display unit as described, it is possible to determine or check for fault tolerance based on the connection of the various segments on each row or column connector. That is, in one embodiment, for each row or column connector that connects a predetermined set of segments together, a layout similar to that shown in FIG. 5 may be generated which illustrates, for example, a row connector based on a single pad failure in which segments A and F are not functioning.


Referring again to FIG. 5, with the segments A and F in failure mode, the only number or value whose displayed accuracy is maintained is value “1”, while the value for the original number “7” is erroneously shown as a “1”. All other remaining values are provided as nonsensical number. For example, the original number “2” is now displayed with the top A segment disabled which has no representative value. In this manner, it is possible to determine the impact of row or common connector failures on a seven segment display.



FIG. 6A illustrates a three digit segment layout with icons for an electronic device LCD display unit, and FIG. 6B illustrates the three digit segment layout of FIG. 6A with multiple row and column connectors. More specifically, as shown in FIG. 6B, each of the three row connectors (row 1, row 2 and row 3) and each of the six common connectors (comm 1, comm 2, comm 3, comm 4, comm 5, and comm 6), are respectively connected to a corresponding segment(s) in one or more of the three 7-digit display. For example, it can be seen from FIG. 6B that row 1 connector or pad is connected to segments 1A and 1B of the most significant digit, segments 2A and 2B of the less significant digit, and to segments 3A and 3B of the least significant digit (to the right of the decimal point DP).


A common failure in a seven-segment LCD display unit is having a pad or connector loose contact, resulting in a loss of the respective segment(s). This failure generally occurs near the outer edges of the LCD connector for heat seal connectors. To reduce the impact of this type of failure, in one embodiment, with reference to FIG. 6B, the critical segments of the display (for example, segments whose failures have substantial impact upon the displayed readout) may be located near the middle of the connector. When this type of failure occurs, often there are two adjacent pads that fail simultaneously. In order to avoid losing two critical segments at the same time, a pad or connector that is not as critical, such as that connected to a non critical icon, may be positioned between the two critical segments.


Moreover, this approach in one embodiment may be applied to the display unit configuration as shown in FIG. 4 that includes a single common connector (comm1) with multiple pad connectors. Furthermore, the decimal point for such displays as shown in FIG. 4 may be controlled by a pad such that it is between the pads controlling segments C and D of a relevant digit. This approach in one embodiment may not prevent all errors from occurring, but will mitigate the effect and frequency of these errors as either segments C or D are used in each number displayed.



FIG. 7 illustrates a segmented display configuration for 3×3 mapping in a fault tolerant display system in accordance with one embodiment of the present invention. Referring to FIG. 7, the seven segments and the decimal point DP are each correspondingly connected to a plurality of the row or common pad connectors (row 1, row 2, row 3, and comm 1, comm 2, and comm 3), and arranged as shown in Table B below.














TABLE B








Comm 1
Comm 2
Comm 3























Row 1
F
B
DP




Row 2
D
A
C




Row 3
**
G
E










The row 3/comm 1 location indicated with “**” may be used for another icon or other symbols on the display but which is not needed for the primary display segments.


In this manner, it can be seen that the possibility of an erroneous number or value displayed is substantially minimized. More specifically, for example as shown in the embodiment of FIG. 7, when one of the pad connectors (row 1, row 2, row 3, and comm 1, comm 2, and comm 3) fails, then the resulting display will not be a number, but rather, a nonsensical display output. Moreover, the configuration shown in FIG. 7 in one embodiment provides for the decimal point DP to be missing (when the corresponding pad fails) concurrent with a substantially noticeably error in the output value of one of the digits.


For example, if row 2 connector fails, then segments A, C and D fail, resulting in a display of nonsensical number. Moreover, if comm 3 connector fails, then the decimal point DP fails in addition to segments C and E, again, rendering the output display to be nonsensical, and with the disabled decimal point DP. In this manner, in one embodiment of the present invention, a substantially fault tolerant seven segment LCD display configuration is provided which substantially minimizes the possibility of erroneously displaying a value to the patient and which may be the basis of inaccurate and/or inappropriate patient treatment.



FIG. 8 illustrates a segmented display configuration for 6×6 mapping in a fault tolerant display system in accordance with another embodiment of the present invention. Referring to FIG. 8, it can be seen that the output display for the 6×6 mapping provides a three digit seven-segment display suitable for a blood glucose meter 101 (FIG. 1) for example, for displaying a range of measured glucose values. More specifically, compared with the embodiment shown in FIG. 7 for a single digit 3×3 mapping of the three row connectors and three common connectors, in the embodiment shown in FIG. 8, there are provided six row connectors (row 1, row 2, row 3, row 4, row 5, and row 6) and six common connectors (comm 1, comm 2, comm 3, comm 4, comm 5, and comm 6) using similar mapping configuration as the single digit configuration of FIG. 7. This configuration provides additional or further fault tolerance against a missing first digit as compared to three 3×3 mapping in sequence.



FIG. 9 illustrates a segmented display configuration for 6×4 mapping in a fault tolerant display system in accordance with still another embodiment of the present invention. Referring to FIG. 9, provided with four row connectors (row 1, row 2, row 3, and row 4) and six common pads or connectors (comm 1, comm 2, comm 3, comm 4, comm 5, and comm 6), the layout shown in Table C may be used.













TABLE C






Row 4
Row 3
Row 2
Row 1



















Comm 1
3C
**
1D
1F


Comm 2
3B
1G
1A
1B


Comm 3
3D
1E
1C
*


Comm 4
3G
3E
2D
2F


Comm 5
3F
2G
2A
2B


Comm 6
3A
2E
2C
DP









The location indicated with a “*” may be used for a second decimal point (DP) if needed or alternatively, for an icon displayed on the display unit, and the location indicated with a “**” may be used for icons or other symbols on the display but is not needed for the segments.


In one embodiment, the layout shown in FIG. 9 is configured to prevent the first and second digits, including the decimal point, from resulting in a numerical error. The third digit, however, may result in a missing digit or a numerical error. In glucose meters, the errors that result from the third digit will be are sufficiently insignificant (clinically) that they are contained in the A or B region of the Clarke Error Grid, and thus erroneous reading or display will likely not result in substantial misdiagnosis or significant improper treatment of the patient.



FIG. 10 is a tabular illustration of the fault tolerant display for LCD display unit in an electronic device with varying levels of fault tolerance for illustrating the various embodiments of the present invention described herein. For example, a correct reading of a glucose meter at 140 shown by the first entry in the first column in Table C, will result in a bad reading if the most significant digit “1” is missing. Accordingly, in one embodiment, the display unit may be configured such that the bad reading of “40” is instead configured to be output as a good reading as shown in the corresponding row of Table C in the third column. Indeed, the good reading is displayed as a nonsensical value which is not likely to mislead the patient that the 10 measured glucose level is 40 rather than 140 which is the actual accurate value.


In yet another embodiment of the present invention, there is provided a fault tolerant three digit LCD display unit which does not display any cross point pixels (pixels that are always displayed caused by a row connector and a common connector crossing). In this case, a 4×12 mapping may be used in accordance with the layout 15 shown in Table D below which includes twelve row connectors and four common connectors.















TABLE D








Comm 1
Comm 2
Comm 3
Comm 4
























Row 1



1D




Row 2


1E
1C




Row 3
1A
1F






Row 4

1B
1G





Row 5


2E
2C




Row 6
2A
2F






Row 7

2B
2G
DP




Row 8
3A
3F






Row 9

3B
3G





Row 10


3E
3C




Row 11



3D




Row 12



2D










In this manner, inadvertent display errors may be mitigated while also minimizing the number of cross point pixels on an LCD. The third digit for this method can also be located in other locations in the truth table without sacrificing fault tolerance as it is not a critical digit. The open spaces in Table E shown with the “-” may be used for icons or other symbols, provided that they do not create cross points between the rows and commons (columns). This approach in one embodiment eliminates critical errors, such as missing decimal point and missing first digit, but may not eliminate all errors. However, the errors that occur will fall into either the A or B region of the Clarke Error Grid, that is, within the acceptable tolerance range, and thus prove to be clinically acceptable.


In this manner, in accordance with the various embodiments of the present invention, there is provided a method and system for fault tolerant configuration of a seven segment display of an electronic device including medical devices such as the LCD display of a glucose meter. That is, if an LCD failure occurs, the result displayed will not be a number, or alternatively, the erroneous number displayed are in the A or B region of the Clarke Error Grid (that is, in the acceptable/tolerance range of values in the case of measured glucose values). Therefore, the fault tolerance approach in accordance with the present invention minimizes the chance of an incorrect number being displayed and reduces the effect of a potential error on patient treatment.


In accordance with the various embodiments of the present invention, there is provided a fault tolerant display unit which may be configured to mitigate the effects of display failure. More specifically, in one embodiment, if a display failure occurs (by, for example, a single pixel or multiple pixels failures and/or pad or connector failures), the displayed results may be configured to display an invalid number. Alternatively, in the case of glucose meters, the display failure may be mitigated by displaying, in one embodiment, measured glucose values that are within the A or B region of the Clarke Error Grid.


In this manner, in one embodiment, the probability of an incorrect value being displayed can be minimized, and the effect of a potential error on the patient treatment (based on incorrect value) may be reduced if an incorrect number is displayed.


Indeed, an apparatus including a fault tolerant display unit for an electronic device in one embodiment of the present invention includes a display unit, a controller unit operatively coupled to the display unit, the controller unit configured to control the display unit to display information, where when a failure mode of the display unit occurs, the display unit is configured to display modified information, where the modified information is different from the information for display under the control of the controller unit.


The display unit in one embodiment may include a seven segment Liquid Crystal Display (LCD) unit with one or more digits.


Additionally, the display unit may be configured to display one or more health related values, where the one or more health related values may include one or more of a measured glucose value, a cholesterol level, and a blood alcohol level.


The failure mode of the display unit in one embodiment includes one or more of a connector failure, a display unit driver failure, or a connector short.


Moreover, one of an RF receiver unit, wherein the display unit may be coupled to a housing of the RF receiver unit.


In an another embodiment, an infusion device may also be provided, where the display unit may be coupled to a housing of the infusion device. The infusion device may include an external insulin pump, an implantable insulin pump, or an on-body patch pump.


Moreover, in a further embodiment, a glucose meter may be provided, where the display unit is coupled to a housing of the glucose meter.


The displayed modified information associated with the detected failure mode in one embodiment is non-informative.


A method of providing display fault tolerance in an electronic device in another embodiment includes the steps of receiving one or more commands to display information on a display unit, detecting a failure mode associated with the display unit, and displaying modified information on the display unit associated with the detected failure mode.


In one embodiment, the step of displaying may include the step of disabling a predetermined segment of the information for display such that the displayed information is a subset of the information for display, and further, where the subset of the information for display may be non-informative.


A display unit of an electronic device in yet another embodiment of the present invention includes a display portion, and a controller coupled to the display portion, the display portion configured to display a predetermined information based on one or more commands received from the controller, where, when a failure mode is detected in the display portion, the one or more commands received from the controller to display the predetermined information does not change.


Various other modifications and alterations in the structure and method of operation of this invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. It is intended that the following claims define the scope of the present invention and that structures and methods within the scope of these claims and their equivalents be covered thereby.

Claims
  • 1. A method of providing display fault tolerance in an electronic device, comprising: receiving one or more commands to display an information on a display unit, the display unit comprising a first display portion including a first plurality of display segments and a first plurality of connectors, a second display portion including a second plurality of display segments and a second plurality of connectors, and a third display portion including a third plurality of display segments and a third plurality of connectors, wherein each connector is connected to a different combination of two or more display segments in one or more of the first display portion, the second display portion, and the third display portion;detecting a failure mode of the display unit, the failure mode resulting from failure of at least one connector;determining if the failure is related to one or more of the first display portion, the second display portion, and the third display portion; anddisplaying a modified information on the display unit indicating the detected failure mode of the display unit if it is determined that the failure is related to at least one of the first display portion and the second display portion, the modified information represented by a first predetermined number of display segments in each of the first display portion, the second display portion, and the third display portion, the step of displaying including disabling one or more segments represented by a second predetermined number of display segments in each of the first display portion, the second display portion, and the third display portion; wherein the first predetermined number of display segments is a subset of the second predetermined number of display segments;wherein each display segment that is connected to the failed at least one connector is disabled; andwherein if it is determined that the failure is only related to the third display segment, a modified information is not displayed by the display unit.
  • 2. The method of claim 1 wherein the information for display includes one or more health related values.
  • 3. The method of claim 2 wherein the one or more health related values includes one or more of a measured glucose value, a cholesterol level, and a blood alcohol level.
  • 4. The method of claim 1 wherein the detected failure mode includes one or more of a display unit connector failure, a display unit driver failure, or a display unit connector short.
  • 5. The method of claim 1 further including the step of coupling the display unit to one of an RF receiver unit, an infusion device, or a glucose meter.
  • 6. The method of claim 1 wherein the first predetermined number of segments representing the displayed modified information associated with the detected failure mode is a subset of a combination of display segments representing a numerical value for each of the first display portion, the second display portion, and the third display portion.
  • 7. The method of claim 1 wherein the second predetermined number of display segments represents a numerical value in each of the first display portion, the second display portion, and the third display portion.
  • 8. The method of claim 1 wherein the second predetermined number of display segments in each of the first display portion, the second display portion, and the third display portion represents a glucose value.
  • 9. The method of claim 1 wherein receiving one or more commands to display the information on the display unit includes detecting insertion of an in vitro test strip in a strip port.
  • 10. The method of claim 9 wherein the in vitro test strip includes a blood glucose test strip.
  • 11. The method of claim 1 wherein the display unit includes a seven segment display unit.
  • 12. The method of claim 1 wherein the second predetermined number of display segments includes seven display segments or less in each of the first display portion, the second display portion, and the third display portion, and further, wherein the first predetermined number of display segments includes less than seven display segments in each of the first display portion, the second display portion, and the third display portion.
  • 13. The method of claim 1 wherein the modified information represented by the first predetermined number of display segments includes only a subset of the display segments that represent a numerical value in each of the first display portion, the second display portion, and the third display portion.
  • 14. The method of claim 1 wherein each display segment is connected to a combination of two connectors.
  • 15. The method of claim 14 wherein the combination of two connectors for each display segment is different.
  • 16. An apparatus, comprising: a display unit;one or more processors operatively coupled to the display unit, the display unit comprising a first display portion including a first plurality of display segments and a first plurality of connectors, a second display portion including a second plurality of display segments and a second plurality of connectors, and a third display portion including a third plurality of display segments and a third plurality of connectors, wherein each connector is connected to a different combination of two or more display segments in one or more of the first display portion, the second display portion, and the third display portion; anda memory for storing instructions which, when executed by the one or more processors, causes the one or more processors to display an information on the display unit, to detect a failure mode of the display unit, the failure mode resulting from failure of at least one connector, to determine if the failure is related to one or more of the first display portion, the second display portion, and the third display portion, to disable one or more segments in each of the first display portion, the second display portion, and the third display portion of the information for display represented by a second predetermined number of display segments if it is determined that the failure is related to at least one of the first display portion and the second display portion, and to display a modified information on the display unit indicating the detected failure mode of the display unit, the modified information represented by a first predetermined number of display segments in one or more of the first display portion, the second display portion, and the third display portion, wherein the first predetermined number of display segments is a subset of the second predetermined number of display segments, wherein each display segment that is connected to the failed at least one connector is disabled, and wherein if it is determined that the failure is only related to the third display segment, a modified information is not displayed by the display unit.
  • 17. The apparatus of claim 16 wherein the information for display includes one or more health related values.
  • 18. The apparatus of claim 17 wherein the one or more health related values includes one or more of a measured glucose value, a cholesterol level, and a blood alcohol level.
  • 19. The apparatus of claim 16 wherein the detected failure mode includes one or more of a display unit connector failure, a display unit driver failure, or a display unit connector short.
  • 20. The apparatus of claim 16 wherein the first predetermined number of segments representing the displayed modified information associated with the detected failure mode is a subset of a combination of display segments representing a numerical value in each of the first display portion, the second display portion, and the third display portion.
  • 21. The apparatus of claim 16 wherein the second predetermined number of display segments represents a numerical value in each of the first display portion, the second display portion, and the third display portion.
  • 22. The apparatus of claim 16 wherein the second predetermined number of display segments in each of the first display portion, the second display portion, and the third display portion represents a glucose value.
  • 23. The apparatus of claim 16 further comprising a strip port operatively coupled to the one or more processors, wherein the information for display on the display unit includes information determined from an in vitro test strip in the strip port.
  • 24. The apparatus of claim 23 wherein the in vitro test strip includes a blood glucose test strip.
  • 25. The apparatus of claim 16 wherein the display unit includes a seven segment display unit.
  • 26. The apparatus of claim 16 wherein the second predetermined number of display segments includes seven display segments or less in each of the first display portion, the second display portion, and the third display portion, and further, wherein the first predetermined number of display segments includes less than seven display segments in each of the first display portion, the second display portion, and the third display portion.
  • 27. The apparatus of claim 16 wherein the modified information represented by the first predetermined number of display segments includes only a subset of the display segments that represent a numerical value in each of the first display portion, the second display portion, and the third display portion.
US Referenced Citations (938)
Number Name Date Kind
2915579 Mendelsohn Dec 1959 A
3374337 Burley Mar 1968 A
3606592 Madurski et al. Sep 1971 A
3750687 Williams Aug 1973 A
3843455 Bier Oct 1974 A
3923060 Ellinwood Dec 1975 A
3930493 Williamson Jan 1976 A
3938140 Garcia et al. Feb 1976 A
3994799 Yao et al. Nov 1976 A
4018547 Rogen Apr 1977 A
4121282 Ohsawa Oct 1978 A
4146029 Ellinwood Mar 1979 A
4193397 Tucker et al. Mar 1980 A
4268173 Barnard et al. May 1981 A
4288793 Lotscher Sep 1981 A
4362052 Heath et al. Dec 1982 A
4401122 Clark, Jr. Aug 1983 A
4439197 Honda et al. Mar 1984 A
4447224 DeCant, Jr. et al. May 1984 A
4458686 Clark, Jr. Jul 1984 A
4467811 Clark, Jr. Aug 1984 A
4472113 Rogen Sep 1984 A
4494950 Fischell Jan 1985 A
4512348 Uchigaki et al. Apr 1985 A
4524343 Morgan et al. Jun 1985 A
4529401 Leslie et al. Jul 1985 A
4531235 Brusen Jul 1985 A
4562751 Nason et al. Jan 1986 A
4563249 Hale Jan 1986 A
4570492 Walsh Feb 1986 A
4573994 Fischell et al. Mar 1986 A
4633878 Bombardieri Jan 1987 A
4678408 Nason et al. Jul 1987 A
4685903 Cable et al. Aug 1987 A
4686624 Blum et al. Aug 1987 A
4736748 Nakamura et al. Apr 1988 A
4755173 Konopka et al. Jul 1988 A
4811564 Palmer Mar 1989 A
4850959 Findl Jul 1989 A
4851827 Nicholas Jul 1989 A
4866396 Tamura Sep 1989 A
4890621 Hakky Jan 1990 A
4953552 DeMarzo Sep 1990 A
4976590 Baldwin Dec 1990 A
4979509 Hakky Dec 1990 A
4984581 Stice Jan 1991 A
5004532 Hale et al. Apr 1991 A
5012667 Kruse May 1991 A
5019974 Beckers May 1991 A
5036861 Sembrowich et al. Aug 1991 A
5051880 Harm et al. Sep 1991 A
5061914 Busch et al. Oct 1991 A
5079920 Whitehead et al. Jan 1992 A
5081421 Miller et al. Jan 1992 A
5101814 Palti Apr 1992 A
5124661 Zelin et al. Jun 1992 A
5139023 Stanley et al. Aug 1992 A
5190041 Palti Mar 1993 A
5205819 Ross et al. Apr 1993 A
5207666 Idriss et al. May 1993 A
5211371 Coffee May 1993 A
5211626 Frank et al. May 1993 A
5262305 Heller et al. Nov 1993 A
5278997 Martin Jan 1994 A
5284423 Holdsworth et al. Feb 1994 A
5291614 Baker et al. Mar 1994 A
5291887 Stanley et al. Mar 1994 A
5324599 Oyama et al. Jun 1994 A
5325280 Tortola et al. Jun 1994 A
5349852 Kamen et al. Sep 1994 A
5356786 Heller et al. Oct 1994 A
5366292 Voss Nov 1994 A
5368028 Palti Nov 1994 A
5371687 Holmes, II et al. Dec 1994 A
5372133 Hogen Esch Dec 1994 A
5376070 Purvis et al. Dec 1994 A
5382331 Banks Jan 1995 A
5390671 Lord et al. Feb 1995 A
5391250 Cheney, II et al. Feb 1995 A
5398681 Kuperschmidt Mar 1995 A
5404585 Vimpari et al. Apr 1995 A
5406301 Ravid Apr 1995 A
5445611 Eppstein et al. Aug 1995 A
5448992 Kuperschmidt Sep 1995 A
5458140 Eppstein et al. Oct 1995 A
5469025 Kanemori et al. Nov 1995 A
5494562 Maley et al. Feb 1996 A
5497772 Schulman et al. Mar 1996 A
5505713 Van Antwerp Apr 1996 A
5507288 Bocker et al. Apr 1996 A
5515390 Benton May 1996 A
5517434 Hanson et al. May 1996 A
5526844 Kamen et al. Jun 1996 A
5533389 Kamen et al. Jul 1996 A
5543678 Hoiberg Aug 1996 A
5559528 Ravid et al. Sep 1996 A
5568400 Stark et al. Oct 1996 A
5568806 Cheney, II et al. Oct 1996 A
5575770 Melsky et al. Nov 1996 A
5576535 Oosterwijk et al. Nov 1996 A
5586553 Halili et al. Dec 1996 A
5593852 Heller et al. Jan 1997 A
5594906 Holmes, II et al. Jan 1997 A
5601435 Quy Feb 1997 A
5604404 Sahara Feb 1997 A
5615671 Schoonen et al. Apr 1997 A
5622413 Kim et al. Apr 1997 A
5622482 Lee Apr 1997 A
5640954 Pfeiffer et al. Jun 1997 A
5645709 Birch et al. Jul 1997 A
5660163 Schulman et al. Aug 1997 A
5661643 Blakely et al. Aug 1997 A
5662461 Ono Sep 1997 A
5671301 Kuperschmidt Sep 1997 A
5695949 Galen et al. Dec 1997 A
5703928 Galloway et al. Dec 1997 A
5707502 McCaffrey et al. Jan 1998 A
5708247 McAleer et al. Jan 1998 A
5711861 Ward et al. Jan 1998 A
5711868 Maley et al. Jan 1998 A
5722397 Eppstein Mar 1998 A
5741211 Renirie et al. Apr 1998 A
5748872 Norman May 1998 A
5759510 Pillai Jun 1998 A
5771890 Tamada Jun 1998 A
5774254 Berlin Jun 1998 A
5786439 Van Antwerp et al. Jul 1998 A
5790297 Berlin Aug 1998 A
5791344 Schulman et al. Aug 1998 A
5812102 Sprole et al. Sep 1998 A
5814599 Mitragotri et al. Sep 1998 A
5815303 Berlin Sep 1998 A
5822715 Worthington et al. Oct 1998 A
5825488 Kohl et al. Oct 1998 A
5848990 Cirelli et al. Dec 1998 A
5851197 Marano et al. Dec 1998 A
5873026 Reames Feb 1999 A
5885211 Eppstein et al. Mar 1999 A
5899855 Brown May 1999 A
5913833 Elstrom et al. Jun 1999 A
5918603 Brown Jul 1999 A
5923512 Brownlow et al. Jul 1999 A
5947921 Johnson et al. Sep 1999 A
5948512 Kubota et al. Sep 1999 A
5951836 McAleer et al. Sep 1999 A
5954643 Van Antwerp et al. Sep 1999 A
5965380 Heller et al. Oct 1999 A
5968011 Larsen et al. Oct 1999 A
5971922 Arita et al. Oct 1999 A
6001067 Shults et al. Dec 1999 A
6002961 Mitragotri et al. Dec 1999 A
6011486 Casey Jan 2000 A
6014577 Henning et al. Jan 2000 A
6017328 Fischell et al. Jan 2000 A
6018678 Mitragotri et al. Jan 2000 A
6023629 Tamada Feb 2000 A
6024539 Blomquist et al. Feb 2000 A
6026320 Carlson et al. Feb 2000 A
6027459 Shain et al. Feb 2000 A
6027496 Loomis et al. Feb 2000 A
6027692 Galen et al. Feb 2000 A
6032059 Henning et al. Feb 2000 A
6041253 Kost et al. Mar 2000 A
6041665 Hussain Mar 2000 A
6059546 Brenan et al. May 2000 A
6063039 Cunningham et al. May 2000 A
6064368 Kang May 2000 A
6066243 Anderson et al. May 2000 A
6067017 Stewart et al. May 2000 A
6067463 Jeng et al. May 2000 A
6071249 Cunningham et al. Jun 2000 A
6071251 Cunningham et al. Jun 2000 A
6073031 Helstab et al. Jun 2000 A
6077660 Wong et al. Jun 2000 A
6081104 Kern Jun 2000 A
6083710 Heller et al. Jul 2000 A
6085871 Karamata Jul 2000 A
6086575 Mejslov Jul 2000 A
6091975 Daddona et al. Jul 2000 A
6093156 Cunningham et al. Jul 2000 A
6093172 Funderburk et al. Jul 2000 A
6121009 Heller et al. Sep 2000 A
6129823 Hughes et al. Oct 2000 A
6132371 Dempsey et al. Oct 2000 A
6142939 Eppstein et al. Nov 2000 A
6144303 Federman Nov 2000 A
6144869 Berner et al. Nov 2000 A
6144922 Douglas et al. Nov 2000 A
6147342 Kucher Nov 2000 A
6154855 Norman Nov 2000 A
6155992 Henning et al. Dec 2000 A
6157442 Raskas Dec 2000 A
6160449 Klomsdorf et al. Dec 2000 A
6162202 Sicurelli et al. Dec 2000 A
6162611 Heller et al. Dec 2000 A
6164284 Schulman et al. Dec 2000 A
6173160 Liimatainen Jan 2001 B1
6175752 Say et al. Jan 2001 B1
6180416 Kurnik et al. Jan 2001 B1
6185452 Schulman et al. Feb 2001 B1
6201980 Darrow et al. Mar 2001 B1
6206841 Cunningham et al. Mar 2001 B1
6208894 Schulman et al. Mar 2001 B1
6212416 Ward et al. Apr 2001 B1
6215206 Chitayat Apr 2001 B1
6222514 DeLuca Apr 2001 B1
6232370 Kubota et al. May 2001 B1
6233471 Berner et al. May 2001 B1
6233539 Brown May 2001 B1
6242961 Liu et al. Jun 2001 B1
6245060 Loomis et al. Jun 2001 B1
6248067 Causey, III et al. Jun 2001 B1
6262708 Chu Jul 2001 B1
6272364 Kurnik Aug 2001 B1
6278425 DeLuca Aug 2001 B1
6280587 Matsumoto Aug 2001 B1
6283926 Cunningham et al. Sep 2001 B1
6284478 Heller et al. Sep 2001 B1
6288653 Shih Sep 2001 B1
6293925 Safabash et al. Sep 2001 B1
6295506 Heinonen et al. Sep 2001 B1
6298254 Tamada Oct 2001 B2
6298255 Cordero et al. Oct 2001 B1
6299578 Kurnik et al. Oct 2001 B1
6301499 Carlson et al. Oct 2001 B1
6306104 Cunningham et al. Oct 2001 B1
6309351 Kurnik et al. Oct 2001 B1
6312888 Wong et al. Nov 2001 B1
6315721 Schulman et al. Nov 2001 B2
6326160 Dunn et al. Dec 2001 B1
6329161 Heller et al. Dec 2001 B1
6341232 Conn et al. Jan 2002 B1
6356776 Berner et al. Mar 2002 B1
6360888 McIvor et al. Mar 2002 B1
6366793 Bell et al. Apr 2002 B1
6368141 Van Antwerp et al. Apr 2002 B1
6368274 Van Antwerp et al. Apr 2002 B1
6372371 Iarochenko et al. Apr 2002 B1
6375344 Hanson et al. Apr 2002 B1
6375638 Nason et al. Apr 2002 B2
6377894 Deweese et al. Apr 2002 B1
6379301 Worthington et al. Apr 2002 B1
6381496 Meadows et al. Apr 2002 B1
6393318 Conn et al. May 2002 B1
6403944 MacKenzie et al. Jun 2002 B1
6405066 Essenpreis et al. Jun 2002 B1
6408402 Norman Jun 2002 B1
6417074 Kopley et al. Jul 2002 B2
6419642 Marchitto et al. Jul 2002 B1
6425829 Julien Jul 2002 B1
6427088 Bowman, IV et al. Jul 2002 B1
6432585 Kawakami et al. Aug 2002 B1
6437379 Kopley et al. Aug 2002 B2
6438385 Heinonen et al. Aug 2002 B1
6438414 Conn et al. Aug 2002 B1
6442413 Silver Aug 2002 B1
6461329 Van Antwerp et al. Oct 2002 B1
6462162 Van Antwerp et al. Oct 2002 B2
6464848 Matsumoto Oct 2002 B1
6466807 Dobson et al. Oct 2002 B1
6466810 Ward et al. Oct 2002 B1
6468222 Mault et al. Oct 2002 B1
6471980 Sirhan et al. Oct 2002 B2
6472991 Schulman et al. Oct 2002 B1
6475196 Vachon Nov 2002 B1
6478736 Mault Nov 2002 B1
6480730 Darrow et al. Nov 2002 B2
6482158 Mault Nov 2002 B2
6484045 Holker et al. Nov 2002 B1
6485138 Kubota et al. Nov 2002 B1
6485461 Mason et al. Nov 2002 B1
6492180 Brown et al. Dec 2002 B2
6506168 Fathallah et al. Jan 2003 B1
6513532 Mault et al. Feb 2003 B2
6514460 Fendrock Feb 2003 B1
6514689 Han et al. Feb 2003 B2
6514718 Heller et al. Feb 2003 B2
6522530 Bang Feb 2003 B2
6525330 Paolini et al. Feb 2003 B2
6526298 Khalil et al. Feb 2003 B1
6529772 Carlson et al. Mar 2003 B2
6530915 Eppstein et al. Mar 2003 B1
6535753 Raskas Mar 2003 B1
6537243 Henning et al. Mar 2003 B1
6540675 Aceti et al. Apr 2003 B2
6540891 Stewart et al. Apr 2003 B1
6544212 Galley et al. Apr 2003 B2
6546269 Kurnik Apr 2003 B1
6549796 Sohrab Apr 2003 B2
6551276 Mann et al. Apr 2003 B1
6554798 Mann et al. Apr 2003 B1
6558320 Causey, III et al. May 2003 B1
6558321 Burd et al. May 2003 B1
6558351 Steil et al. May 2003 B1
6560471 Heller et al. May 2003 B1
6561978 Conn et al. May 2003 B1
6562001 Lebel et al. May 2003 B2
6564105 Starkweather et al. May 2003 B2
6564807 Schulman et al. May 2003 B1
6565509 Say et al. May 2003 B1
6565738 Henning et al. May 2003 B1
6569157 Shain et al. May 2003 B1
6571128 Lebel et al. May 2003 B2
6571200 Mault May 2003 B1
6576117 Iketaki et al. Jun 2003 B1
6577899 Lebel et al. Jun 2003 B2
6579498 Eglise Jun 2003 B1
6579690 Bonnecaze et al. Jun 2003 B1
6582393 Sage, Jr. Jun 2003 B2
6585644 Lebel et al. Jul 2003 B2
6586971 Naffziger et al. Jul 2003 B1
6587705 Berner et al. Jul 2003 B1
6589229 Connelly et al. Jul 2003 B1
6594514 Berner et al. Jul 2003 B2
6595919 Berner et al. Jul 2003 B2
6596016 Vreman et al. Jul 2003 B1
6600997 Deweese et al. Jul 2003 B2
6602469 Maus et al. Aug 2003 B1
6607509 Bobroff et al. Aug 2003 B2
6610012 Mault Aug 2003 B2
6612306 Mault Sep 2003 B1
6615061 Khalil et al. Sep 2003 B1
6615074 Mickle et al. Sep 2003 B2
6618603 Varalli et al. Sep 2003 B2
6620106 Mault Sep 2003 B2
6629934 Mault et al. Oct 2003 B2
6633095 Swope et al. Oct 2003 B1
6633772 Ford et al. Oct 2003 B2
6635014 Starkweather et al. Oct 2003 B2
6641533 Causey, III et al. Nov 2003 B2
6645142 Braig et al. Nov 2003 B2
6648821 Lebel et al. Nov 2003 B2
6650064 Guthrie et al. Nov 2003 B2
6653091 Dunn et al. Nov 2003 B1
6656158 Mahoney et al. Dec 2003 B2
6656159 Flaherty Dec 2003 B2
6659948 Lebel et al. Dec 2003 B2
6668196 Villegas et al. Dec 2003 B1
6669663 Thompson Dec 2003 B1
6669669 Flaherty et al. Dec 2003 B2
6670806 Wendt et al. Dec 2003 B2
6679841 Bojan et al. Jan 2004 B2
6687522 Tamada Feb 2004 B2
6687546 Lebel et al. Feb 2004 B2
6692457 Flaherty Feb 2004 B2
6694191 Lebel et al. Feb 2004 B2
6695885 Schulman et al. Feb 2004 B2
6699218 Flaherty et al. Mar 2004 B2
6702857 Brauker et al. Mar 2004 B2
6723072 Flaherty et al. Apr 2004 B2
6728560 Kollias et al. Apr 2004 B2
6730200 Stewart et al. May 2004 B1
6731976 Penn et al. May 2004 B2
6733446 Lebel et al. May 2004 B2
6736777 Kim et al. May 2004 B2
6736797 Larsen et al. May 2004 B1
6738654 Sohrab May 2004 B2
6740059 Flaherty May 2004 B2
6740075 Lebel et al. May 2004 B2
6741877 Shults et al. May 2004 B1
6743635 Neel et al. Jun 2004 B2
6749587 Flaherty Jun 2004 B2
6752787 Causey, III et al. Jun 2004 B1
6758810 Lebel et al. Jul 2004 B2
6764581 Forrow et al. Jul 2004 B1
6768425 Flaherty et al. Jul 2004 B2
6770030 Schaupp et al. Aug 2004 B1
6770729 Van Antwerp Aug 2004 B2
6773563 Matsumoto Aug 2004 B2
6779984 Lilie et al. Aug 2004 B2
6790178 Mault et al. Sep 2004 B1
6794195 Colvin, Jr. Sep 2004 B2
6799861 Naghi et al. Oct 2004 B2
6809653 Mann et al. Oct 2004 B1
6810290 Lebel et al. Oct 2004 B2
6811533 Lebel et al. Nov 2004 B2
6811534 Bowman, IV et al. Nov 2004 B2
6813519 Lebel et al. Nov 2004 B2
6816742 Kim et al. Nov 2004 B2
6818348 Venkatesan et al. Nov 2004 B1
6830558 Flaherty et al. Dec 2004 B2
6832114 Whitehurst et al. Dec 2004 B1
6833540 MacKenzie et al. Dec 2004 B2
6835553 Han et al. Dec 2004 B2
6837858 Cunningham et al. Jan 2005 B2
6839596 Nelson et al. Jan 2005 B2
6840912 Kloepfer et al. Jan 2005 B2
6849237 Housefield et al. Feb 2005 B2
6850790 Berner et al. Feb 2005 B2
6859831 Gelvin et al. Feb 2005 B1
6862465 Shults et al. Mar 2005 B2
6872200 Mann et al. Mar 2005 B2
6873268 Lebel et al. Mar 2005 B2
6881551 Heller et al. Apr 2005 B2
6892085 McIvor et al. May 2005 B2
6893396 Schulze et al. May 2005 B2
6895265 Silver May 2005 B2
6898451 Wuori May 2005 B2
6899683 Mault et al. May 2005 B2
6899684 Mault et al. May 2005 B2
6904301 Raskas Jun 2005 B2
6907127 Kravitz et al. Jun 2005 B1
6908535 Rankin et al. Jun 2005 B2
6916159 Rush et al. Jul 2005 B2
6918874 Hatch et al. Jul 2005 B1
6922576 Raskas Jul 2005 B2
6922578 Eppstein et al. Jul 2005 B2
6923764 Aceti et al. Aug 2005 B2
6927749 Klemm Aug 2005 B1
6931327 Goode, Jr. et al. Aug 2005 B2
6936029 Mann et al. Aug 2005 B2
6949816 Brown et al. Sep 2005 B2
6950708 Bowman IV et al. Sep 2005 B2
6952603 Gerber et al. Oct 2005 B2
6955650 Mault et al. Oct 2005 B2
6958129 Galen et al. Oct 2005 B2
6958705 Lebel et al. Oct 2005 B2
6960192 Flaherty et al. Nov 2005 B1
6974437 Lebel et al. Dec 2005 B2
6979326 Mann et al. Dec 2005 B2
6990366 Say et al. Jan 2006 B2
6990372 Perron et al. Jan 2006 B2
6997911 Klitmose Feb 2006 B2
6997920 Mann et al. Feb 2006 B2
6999810 Berner et al. Feb 2006 B2
7003340 Say et al. Feb 2006 B2
7003341 Say et al. Feb 2006 B2
7005857 Stiene et al. Feb 2006 B2
7006858 Silver et al. Feb 2006 B2
7010356 Jog et al. Mar 2006 B2
7011630 Desai et al. Mar 2006 B2
7018360 Flaherty et al. Mar 2006 B2
7020508 Stivoric et al. Mar 2006 B2
7024245 Lebel et al. Apr 2006 B2
7024249 Weisner et al. Apr 2006 B2
7025743 Mann et al. Apr 2006 B2
7029444 Shin et al. Apr 2006 B2
7029455 Flaherty Apr 2006 B2
7034677 Steinthal et al. Apr 2006 B2
7041468 Drucker et al. May 2006 B2
7043287 Khalil et al. May 2006 B1
7052251 Nason et al. May 2006 B2
7067498 Wolf et al. Jun 2006 B2
7070591 Adams et al. Jul 2006 B2
7072738 Bonney et al. Jul 2006 B2
7074307 Simpson et al. Jul 2006 B2
7077328 Krishnaswamy et al. Jul 2006 B2
7079901 Loftin et al. Jul 2006 B1
7081195 Simpson et al. Jul 2006 B2
7083593 Stultz Aug 2006 B2
7086277 Tess et al. Aug 2006 B2
7092762 Loftin et al. Aug 2006 B1
7097983 Markovsky et al. Aug 2006 B2
7098803 Mann et al. Aug 2006 B2
7108711 Vogel et al. Sep 2006 B2
7108778 Simpson et al. Sep 2006 B2
7110803 Shults et al. Sep 2006 B2
7114502 Schulman et al. Oct 2006 B2
7123206 Hess et al. Oct 2006 B2
7133710 Acosta et al. Nov 2006 B2
7134999 Brauker et al. Nov 2006 B2
7136689 Shults et al. Nov 2006 B2
7136704 Schulman Nov 2006 B2
7137964 Flaherty Nov 2006 B2
7144384 Gorman et al. Dec 2006 B2
7149581 Goedeke Dec 2006 B2
7153212 Karten et al. Dec 2006 B1
7154398 Chen et al. Dec 2006 B2
7163511 Conn et al. Jan 2007 B2
7167818 Brown Jan 2007 B2
7171274 Starkweather et al. Jan 2007 B2
7181261 Silver et al. Feb 2007 B2
7186566 Qian Mar 2007 B2
7186791 Bruno et al. Mar 2007 B2
7192450 Brauker et al. Mar 2007 B2
7198603 Penner et al. Apr 2007 B2
7202734 Raab Apr 2007 B1
7205409 Pei et al. Apr 2007 B2
7208119 Kurtock et al. Apr 2007 B1
7211048 Najafi et May 2007 B1
7218017 Chitayat et al. May 2007 B1
7225535 Feldman et al. Jun 2007 B2
7226278 Nason et al. Jun 2007 B2
7226442 Sheppard, Jr. et al. Jun 2007 B2
7226978 Tapsak et al. Jun 2007 B2
7258666 Brown Aug 2007 B2
7266400 Fine et al. Sep 2007 B2
7276029 Goode, Jr. et al. Oct 2007 B2
7283867 Strother et al. Oct 2007 B2
7299080 Acosta et al. Nov 2007 B2
7303549 Flaherty et al. Dec 2007 B2
7310544 Brister et al. Dec 2007 B2
7323091 Gillette et al. Jan 2008 B1
7324949 Bristol et al. Jan 2008 B2
7364592 Carr-Brendel et al. Apr 2008 B2
7366556 Brister et al. Apr 2008 B2
7379765 Petisce et al. May 2008 B2
7424318 Brister et al. Sep 2008 B2
7460898 Brister et al. Dec 2008 B2
7467003 Brister et al. Dec 2008 B2
7471972 Rhodes et al. Dec 2008 B2
7480138 Kogan et al. Jan 2009 B2
7494465 Brister et al. Feb 2009 B2
7497827 Brister et al. Mar 2009 B2
7510526 Merry et al. Mar 2009 B2
7519408 Rasdal et al. Apr 2009 B2
7583190 Reggiardo et al. Sep 2009 B2
7583990 Goode, Jr. et al. Sep 2009 B2
7591801 Brauker et al. Sep 2009 B2
7599726 Goode, Jr. et al. Oct 2009 B2
7602310 Mann et al. Oct 2009 B2
7613491 Boock et al. Nov 2009 B2
7615007 Shults et al. Nov 2009 B2
7620437 Reggiardo Nov 2009 B2
7632228 Brauker et al. Dec 2009 B2
7637868 Saint et al. Dec 2009 B2
7640048 Dobbles et al. Dec 2009 B2
7651596 Petisce et al. Jan 2010 B2
7654956 Brister et al. Feb 2010 B2
7657297 Simpson et al. Feb 2010 B2
7711402 Shults et al. May 2010 B2
7713574 Brister et al. May 2010 B2
7715893 Kamath et al. May 2010 B2
20010016682 Berner et al. Aug 2001 A1
20010016683 Darrow et al. Aug 2001 A1
20010016710 Nason et al. Aug 2001 A1
20010020124 Tamada Sep 2001 A1
20010023095 Kopley et al. Sep 2001 A1
20010024864 Kopley et al. Sep 2001 A1
20010029340 Mault et al. Oct 2001 A1
20010034502 Moberg et al. Oct 2001 A1
20010037060 Thompson et al. Nov 2001 A1
20010037069 Carlson et al. Nov 2001 A1
20010041830 Varalli et al. Nov 2001 A1
20010044581 Mault Nov 2001 A1
20010044588 Mault Nov 2001 A1
20010049470 Mault et al. Dec 2001 A1
20010053891 Ackley Dec 2001 A1
20010056255 Kost et al. Dec 2001 A1
20020002326 Causey, III et al. Jan 2002 A1
20020002328 Tamada Jan 2002 A1
20020004640 Conn et al. Jan 2002 A1
20020010414 Coston et al. Jan 2002 A1
20020019022 Dunn et al. Feb 2002 A1
20020019612 Watanabe et al. Feb 2002 A1
20020026937 Mault Mar 2002 A1
20020027164 Mault et al. Mar 2002 A1
20020028995 Mault Mar 2002 A1
20020032374 Holker et al. Mar 2002 A1
20020040208 Flaherty et al. Apr 2002 A1
20020042090 Heller et al. Apr 2002 A1
20020047867 Mault et al. Apr 2002 A1
20020053637 Conn et al. May 2002 A1
20020062069 Mault May 2002 A1
20020068858 Braig et al. Jun 2002 A1
20020077765 Mault Jun 2002 A1
20020077766 Mault Jun 2002 A1
20020087056 Aceti et al. Jul 2002 A1
20020091312 Berner et al. Jul 2002 A1
20020091454 Vasko Jul 2002 A1
20020103425 Mault Aug 2002 A1
20020107433 Mault Aug 2002 A1
20020107476 Mann et al. Aug 2002 A1
20020109600 Mault et al. Aug 2002 A1
20020118090 Park et al. Aug 2002 A1
20020119711 Van Antwerp et al. Aug 2002 A1
20020124017 Mault Sep 2002 A1
20020133378 Mault et al. Sep 2002 A1
20020161286 Gerber et al. Oct 2002 A1
20020169394 Eppstein et al. Nov 2002 A1
20020177764 Sohrab Nov 2002 A1
20020193679 Malave et al. Dec 2002 A1
20030009133 Ramey Jan 2003 A1
20030023182 Mault et al. Jan 2003 A1
20030023317 Brauker et al. Jan 2003 A1
20030028089 Galley et al. Feb 2003 A1
20030028120 Mault et al. Feb 2003 A1
20030032868 Graskov et al. Feb 2003 A1
20030032874 Rhodes et al. Feb 2003 A1
20030040683 Rule et al. Feb 2003 A1
20030050546 Desai et al. Mar 2003 A1
20030050575 Diermann et al. Mar 2003 A1
20030060692 Ruchti et al. Mar 2003 A1
20030060765 Campbell et al. Mar 2003 A1
20030065257 Mault et al. Apr 2003 A1
20030065273 Mault et al. Apr 2003 A1
20030065274 Mault et al. Apr 2003 A1
20030065275 Mault et al. Apr 2003 A1
20030065308 Lebel et al. Apr 2003 A1
20030078560 Miller et al. Apr 2003 A1
20030100040 Bonnecaze et al. May 2003 A1
20030100821 Heller et al. May 2003 A1
20030105407 Pearce, Jr. et al. Jun 2003 A1
20030107487 Korman et al. Jun 2003 A1
20030108976 Braig et al. Jun 2003 A1
20030118460 Lilie et al. Jun 2003 A1
20030130616 Steil et al. Jul 2003 A1
20030134347 Heller et al. Jul 2003 A1
20030135100 Kim et al. Jul 2003 A1
20030135333 Aceti et al. Jul 2003 A1
20030153820 Berner et al. Aug 2003 A1
20030153821 Berner et al. Aug 2003 A1
20030158472 Sohrab Aug 2003 A1
20030158707 Doi Aug 2003 A1
20030175806 Rule et al. Sep 2003 A1
20030176933 Lebel et al. Sep 2003 A1
20030181851 Mann et al. Sep 2003 A1
20030181852 Mann et al. Sep 2003 A1
20030187338 Say et al. Oct 2003 A1
20030187525 Mann et al. Oct 2003 A1
20030191376 Samuels et al. Oct 2003 A1
20030191431 Mann et al. Oct 2003 A1
20030195403 Berner et al. Oct 2003 A1
20030195462 Mann et al. Oct 2003 A1
20030198558 Nason et al. Oct 2003 A1
20030199825 Flaherty Oct 2003 A1
20030199837 Vachon Oct 2003 A1
20030208110 Mault et al. Nov 2003 A1
20030208113 Mault et al. Nov 2003 A1
20030208133 Mault Nov 2003 A1
20030208154 Close et al. Nov 2003 A1
20030208409 Mault Nov 2003 A1
20030212346 Yuzhakov et al. Nov 2003 A1
20030212364 Mann et al. Nov 2003 A1
20030212379 Bylund et al. Nov 2003 A1
20030217966 Tapsak et al. Nov 2003 A1
20030225360 Eppstein et al. Dec 2003 A1
20030225361 Sabra Dec 2003 A1
20030226695 Mault Dec 2003 A1
20030232370 Trifiro Dec 2003 A1
20030235817 Bartkowiak et al. Dec 2003 A1
20040011671 Shults et al. Jan 2004 A1
20040018486 Dunn et al. Jan 2004 A1
20040019321 Sage et al. Jan 2004 A1
20040027253 Marsh et al. Feb 2004 A1
20040039256 Kawatahara et al. Feb 2004 A1
20040041749 Dixon Mar 2004 A1
20040045879 Shults et al. Mar 2004 A1
20040054263 Moerman et al. Mar 2004 A1
20040059201 Ginsberg Mar 2004 A1
20040064133 Miller et al. Apr 2004 A1
20040072357 Stiene et al. Apr 2004 A1
20040073095 Causey, III et al. Apr 2004 A1
20040085215 Moberg et al. May 2004 A1
20040096959 Stiene et al. May 2004 A1
20040100376 Lye et al. May 2004 A1
20040106858 Say et al. Jun 2004 A1
20040106859 Say et al. Jun 2004 A1
20040106860 Say et al. Jun 2004 A1
20040108226 Polychronakos et al. Jun 2004 A1
20040115067 Rush et al. Jun 2004 A1
20040122353 Shahmirian et al. Jun 2004 A1
20040132220 Fish Jul 2004 A1
20040133092 Kain Jul 2004 A1
20040152622 Keith et al. Aug 2004 A1
20040158137 Eppstein et al. Aug 2004 A1
20040162473 Sohrab Aug 2004 A1
20040164961 Bal et al. Aug 2004 A1
20040167383 Kim et al. Aug 2004 A1
20040167801 Say et al. Aug 2004 A1
20040171921 Say et al. Sep 2004 A1
20040176913 Kawatahara et al. Sep 2004 A1
20040186362 Brauker et al. Sep 2004 A1
20040186365 Jin et al. Sep 2004 A1
20040193025 Steil et al. Sep 2004 A1
20040193090 Lebel et al. Sep 2004 A1
20040199059 Brauker et al. Oct 2004 A1
20040202576 Aceti et al. Oct 2004 A1
20040207054 Brown et al. Oct 2004 A1
20040208780 Faries, Jr. et al. Oct 2004 A1
20040210184 Kost et al. Oct 2004 A1
20040225338 Lebel et al. Nov 2004 A1
20040236200 Say et al. Nov 2004 A1
20040248204 Moerman Dec 2004 A1
20040249250 McGee et al. Dec 2004 A1
20040249253 Racchini et al. Dec 2004 A1
20040249254 Racchini et al. Dec 2004 A1
20040249999 Connolly et al. Dec 2004 A1
20040253736 Stout et al. Dec 2004 A1
20040254429 Yang Dec 2004 A1
20040254434 Goodnow et al. Dec 2004 A1
20040263354 Mann et al. Dec 2004 A1
20050003470 Nelson et al. Jan 2005 A1
20050009126 Andrews et al. Jan 2005 A1
20050010269 Lebel et al. Jan 2005 A1
20050016276 Guan et al. Jan 2005 A1
20050027179 Berner et al. Feb 2005 A1
20050027180 Goode, Jr. et al. Feb 2005 A1
20050027181 Goode, Jr. et al. Feb 2005 A1
20050027462 Goode, Jr. et al. Feb 2005 A1
20050027463 Goode, Jr. et al. Feb 2005 A1
20050031689 Shults et al. Feb 2005 A1
20050033132 Shults et al. Feb 2005 A1
20050038680 McMahon Feb 2005 A1
20050043598 Goode, Jr. et al. Feb 2005 A1
20050043894 Fernandez Feb 2005 A1
20050045476 Neel et al. Mar 2005 A1
20050049473 Desai et al. Mar 2005 A1
20050051580 Ramey Mar 2005 A1
20050053365 Adams et al. Mar 2005 A1
20050054909 Petisce et al. Mar 2005 A1
20050059926 Sage, Jr. et al. Mar 2005 A1
20050065464 Talbot et al. Mar 2005 A1
20050090607 Tapsak et al. Apr 2005 A1
20050090808 Malave et al. Apr 2005 A1
20050112169 Brauker et al. May 2005 A1
20050113657 Alarcon et al. May 2005 A1
20050113658 Jacobson et al. May 2005 A1
20050118726 Scultz et al. Jun 2005 A1
20050121322 Say et al. Jun 2005 A1
20050124873 Shults et al. Jun 2005 A1
20050137471 Haar et al. Jun 2005 A1
20050143635 Kamath Jun 2005 A1
20050143636 Zhang et al. Jun 2005 A1
20050148003 Keith et al. Jul 2005 A1
20050154271 Rasdal et al. Jul 2005 A1
20050161346 Simpson et al. Jul 2005 A1
20050171503 Van Den Berghe et al. Aug 2005 A1
20050171512 Flaherty Aug 2005 A1
20050171513 Mann et al. Aug 2005 A1
20050173245 Feldman et al. Aug 2005 A1
20050176136 Burd et al. Aug 2005 A1
20050177036 Shults et al. Aug 2005 A1
20050181012 Saint et al. Aug 2005 A1
20050182306 Sloan Aug 2005 A1
20050182366 Vogt et al. Aug 2005 A1
20050182451 Griffin et al. Aug 2005 A1
20050187720 Goode, Jr. et al. Aug 2005 A1
20050192557 Brauker et al. Sep 2005 A1
20050195930 Spital et al. Sep 2005 A1
20050199494 Say et al. Sep 2005 A1
20050203360 Brauker et al. Sep 2005 A1
20050203461 Flaherty et al. Sep 2005 A1
20050214892 Kovatchev et al. Sep 2005 A1
20050215871 Feldman et al. Sep 2005 A1
20050215872 Berner et al. Sep 2005 A1
20050235732 Rush Oct 2005 A1
20050238503 Rush et al. Oct 2005 A1
20050238507 DiIanni et al. Oct 2005 A1
20050239154 Feldman et al. Oct 2005 A1
20050239518 D'Agostino et al. Oct 2005 A1
20050245795 Goode, Jr. et al. Nov 2005 A1
20050245799 Brauker et al. Nov 2005 A1
20050249506 Fuse Nov 2005 A1
20050249606 Rush Nov 2005 A1
20050251083 Carr-Brendel et al. Nov 2005 A1
20050261660 Choi Nov 2005 A1
20050267780 Ray et al. Dec 2005 A1
20050271546 Gerber et al. Dec 2005 A1
20050271547 Gerber et al. Dec 2005 A1
20050272640 Doyle, III et al. Dec 2005 A1
20050272985 Kotulla et al. Dec 2005 A1
20050277844 Strother et al. Dec 2005 A1
20050287620 Heller et al. Dec 2005 A1
20060001538 Kraft et al. Jan 2006 A1
20060001550 Mann et al. Jan 2006 A1
20060001551 Kraft et al. Jan 2006 A1
20060003398 Heller et al. Jan 2006 A1
20060004271 Peyser et al. Jan 2006 A1
20060007017 Mann et al. Jan 2006 A1
20060015020 Neale et al. Jan 2006 A1
20060015024 Brister et al. Jan 2006 A1
20060016700 Brister et al. Jan 2006 A1
20060019327 Brister et al. Jan 2006 A1
20060020186 Brister et al. Jan 2006 A1
20060020187 Brister et al. Jan 2006 A1
20060020188 Kamath et al. Jan 2006 A1
20060020189 Brister et al. Jan 2006 A1
20060020190 Kamath et al. Jan 2006 A1
20060020191 Brister et al. Jan 2006 A1
20060020192 Brister et al. Jan 2006 A1
20060025663 Talbot et al. Feb 2006 A1
20060031094 Cohen et al. Feb 2006 A1
20060036139 Brister et al. Feb 2006 A1
20060036140 Brister et al. Feb 2006 A1
20060036141 Kamath et al. Feb 2006 A1
20060036142 Brister et al. Feb 2006 A1
20060036143 Brister et al. Feb 2006 A1
20060036144 Brister et al. Feb 2006 A1
20060036145 Brister et al. Feb 2006 A1
20060036187 Vos et al. Feb 2006 A1
20060040402 Brauker et al. Feb 2006 A1
20060041229 Garibotto et al. Feb 2006 A1
20060052679 Kotulla et al. Mar 2006 A1
20060058602 Kwiatkowski et al. Mar 2006 A1
20060058627 Flaherty et al. Mar 2006 A1
20060063218 Bartowiak et al. Mar 2006 A1
20060074564 Bartkowiak et al. Apr 2006 A1
20060166629 Reggiardo Jul 2006 A1
20060173259 Flaherty et al. Aug 2006 A1
20060173444 Choy et al. Aug 2006 A1
20060178633 Garibotto et al. Aug 2006 A1
20060222566 Brauker et al. Oct 2006 A1
20060224141 Rush et al. Oct 2006 A1
20060247508 Fennell Nov 2006 A1
20060253085 Geismar et al. Nov 2006 A1
20060273759 Reggiardo Dec 2006 A1
20060282290 Flaherty et al. Dec 2006 A1
20070016381 Kamath et al. Jan 2007 A1
20070078323 Reggiardo et al. Apr 2007 A1
20070106135 Sloan May 2007 A1
20070118405 Campbell et al. May 2007 A1
20070135697 Reggiardo Jun 2007 A1
20070163880 Woo et al. Jul 2007 A1
20070173711 Shah et al. Jul 2007 A1
20070203966 Brauker et al. Aug 2007 A1
20070219480 Kamen et al. Sep 2007 A1
20070219597 Kamen et al. Sep 2007 A1
20070235331 Simpson et al. Oct 2007 A1
20080021666 Goode, Jr. et al. Jan 2008 A1
20080033254 Kamath et al. Feb 2008 A1
20080045824 Tapsak et al. Feb 2008 A1
20080064941 Funderburk et al. Mar 2008 A1
20080071156 Brister et al. Mar 2008 A1
20080083617 Simpson et al. Apr 2008 A1
20080086042 Brister et al. Apr 2008 A1
20080086044 Brister et al. Apr 2008 A1
20080086273 Shults et al. Apr 2008 A1
20080103447 Reggiardo et al. May 2008 A1
20080108942 Brister et al. May 2008 A1
20080183061 Goode et al. Jul 2008 A1
20080183399 Goode et al. Jul 2008 A1
20080188731 Brister et al. Aug 2008 A1
20080189051 Goode et al. Aug 2008 A1
20080194935 Brister et al. Aug 2008 A1
20080194936 Goode et al. Aug 2008 A1
20080194937 Goode et al. Aug 2008 A1
20080194938 Brister et al. Aug 2008 A1
20080195232 Carr-Brendel et al. Aug 2008 A1
20080195967 Goode et al. Aug 2008 A1
20080197024 Simpson et al. Aug 2008 A1
20080200788 Brister et al. Aug 2008 A1
20080200789 Brister et al. Aug 2008 A1
20080200791 Simpson et al. Aug 2008 A1
20080208025 Shults et al. Aug 2008 A1
20080214915 Brister et al. Sep 2008 A1
20080214918 Brister et al. Sep 2008 A1
20080228051 Shults et al. Sep 2008 A1
20080228054 Shults et al. Sep 2008 A1
20080242961 Brister et al. Oct 2008 A1
20080262469 Brister et al. Oct 2008 A1
20080275313 Brister et al. Nov 2008 A1
20080287764 Rasdal et al. Nov 2008 A1
20080287765 Rasdal et al. Nov 2008 A1
20080287766 Rasdal et al. Nov 2008 A1
20080296155 Shults et al. Dec 2008 A1
20080306368 Goode et al. Dec 2008 A1
20080306434 Dobbles et al. Dec 2008 A1
20080306435 Kamath et al. Dec 2008 A1
20080306444 Brister et al. Dec 2008 A1
20090012379 Goode et al. Jan 2009 A1
20090018424 Kamath et al. Jan 2009 A1
20090030294 Petisce et al. Jan 2009 A1
20090036758 Brauker et al. Feb 2009 A1
20090036763 Brauker et al. Feb 2009 A1
20090043181 Brauker et al. Feb 2009 A1
20090043182 Brauker et al. Feb 2009 A1
20090043525 Brauker et al. Feb 2009 A1
20090043541 Brauker et al. Feb 2009 A1
20090043542 Brauker et al. Feb 2009 A1
20090045055 Rhodes et al. Feb 2009 A1
20090062633 Brauker et al. Mar 2009 A1
20090062635 Brauker et al. Mar 2009 A1
20090068954 Reggiardo et al. Mar 2009 A1
20090076356 Simpson et al. Mar 2009 A1
20090076358 Reggiardo et al. Mar 2009 A1
20090076360 Brister et al. Mar 2009 A1
20090076361 Kamath et al. Mar 2009 A1
20090083003 Reggiardo et al. Mar 2009 A1
20090099436 Brister et al. Apr 2009 A1
20090124877 Goode, Jr. et al. May 2009 A1
20090124878 Goode et al. May 2009 A1
20090124879 Brister et al. May 2009 A1
20090124964 Leach et al. May 2009 A1
20090131768 Simpson et al. May 2009 A1
20090131769 Leach et al. May 2009 A1
20090131776 Simpson et al. May 2009 A1
20090131777 Simpson et al. May 2009 A1
20090137886 Shariati et al. May 2009 A1
20090137887 Shariati et al. May 2009 A1
20090143659 Li et al. Jun 2009 A1
20090143660 Brister et al. Jun 2009 A1
20090156919 Brister et al. Jun 2009 A1
20090156924 Shariati et al. Jun 2009 A1
20090163790 Brister et al. Jun 2009 A1
20090163791 Brister et al. Jun 2009 A1
20090178459 Li et al. Jul 2009 A1
20090182217 Li et al. Jul 2009 A1
20090192366 Mensinger et al. Jul 2009 A1
20090192380 Shariati et al. Jul 2009 A1
20090192722 Shariati et al. Jul 2009 A1
20090192724 Brauker et al. Jul 2009 A1
20090192745 Kamath et al. Jul 2009 A1
20090192751 Kamath et al. Jul 2009 A1
20090203981 Brauker et al. Aug 2009 A1
20090204341 Brauker et al. Aug 2009 A1
20090216103 Brister et al. Aug 2009 A1
20090240120 Mensinger et al. Sep 2009 A1
20090240128 Mensinger et al. Sep 2009 A1
20090240193 Mensinger et al. Sep 2009 A1
20090242399 Kamath et al. Oct 2009 A1
20090242425 Kamath et al. Oct 2009 A1
20090247855 Boock et al. Oct 2009 A1
20090247856 Boock et al. Oct 2009 A1
20090287073 Boock et al. Nov 2009 A1
20090287074 Shults et al. Nov 2009 A1
20090299155 Yang et al. Dec 2009 A1
20090299156 Simpson et al. Dec 2009 A1
20090299162 Brauker et al. Dec 2009 A1
20090299276 Brauker et al. Dec 2009 A1
20100010324 Brauker et al. Jan 2010 A1
20100010331 Brauker et al. Jan 2010 A1
20100010332 Brauker et al. Jan 2010 A1
20100016687 Brauker et al. Jan 2010 A1
20100016698 Rasdal et al. Jan 2010 A1
20100022855 Brauker et al. Jan 2010 A1
20100030038 Brauker et al. Feb 2010 A1
20100030053 Goode, Jr. et al. Feb 2010 A1
20100030484 Brauker et al. Feb 2010 A1
20100030485 Brauker et al. Feb 2010 A1
20100036215 Goode, Jr. et al. Feb 2010 A1
20100036216 Goode, Jr. et al. Feb 2010 A1
20100036222 Goode, Jr. et al. Feb 2010 A1
20100036223 Goode, Jr. et al. Feb 2010 A1
20100036225 Goode, Jr. et al. Feb 2010 A1
20100041971 Goode, Jr. et al. Feb 2010 A1
20100045465 Brauker et al. Feb 2010 A1
20100049024 Saint et al. Feb 2010 A1
20100063373 Kamath et al. Mar 2010 A1
20100076283 Simpson et al. Mar 2010 A1
20100081908 Dobbles et al. Apr 2010 A1
20100081910 Brister et al. Apr 2010 A1
20100087724 Brauker et al. Apr 2010 A1
20100096259 Zhang et al. Apr 2010 A1
20100099970 Shults et al. Apr 2010 A1
20100099971 Shults et al. Apr 2010 A1
20100119693 Tapsak et al. May 2010 A1
20100121169 Petisce et al. May 2010 A1
Foreign Referenced Citations (34)
Number Date Country
0455455 Nov 1991 EP
0518524 Dec 1992 EP
0878707 Nov 1998 EP
0543916 Jul 2001 EP
1130638 Sep 2001 EP
1755443 Nov 2005 EP
1783536 May 2007 EP
2001-177423 Jun 2001 JP
2001-056673 Nov 2001 JP
WO-9614026 May 1996 WO
WO-9922236 May 1999 WO
WO-0152727 Jul 2001 WO
WO-0171186 Sep 2001 WO
WO-0239086 May 2002 WO
WO-02084860 Oct 2002 WO
WO-02100263 Dec 2002 WO
WO-02100469 Dec 2002 WO
WO-03006091 Jan 2003 WO
WO-2004028337 Apr 2004 WO
WO-2004032994 Apr 2004 WO
WO-2004061420 Jul 2004 WO
WO-2005089103 Sep 2005 WO
WO-2005101994 Nov 2005 WO
WO-2006003919 Jan 2006 WO
WO-2006079114 Jul 2006 WO
WO-2006086701 Aug 2006 WO
WO-2006102412 Sep 2006 WO
WO-2006110913 Oct 2006 WO
WO-2006113408 Oct 2006 WO
WO-2006113521 Oct 2006 WO
WO-2006118947 Nov 2006 WO
WO-2006132884 Dec 2006 WO
WO-2007041072 Apr 2007 WO
WO-2008055037 May 2008 WO
Related Publications (1)
Number Date Country
20070176867 A1 Aug 2007 US